Abstract
Objective
To date, there are no epidemiological data on microscopic colitis (MC) in France. The aim of this study was to determine the incidence of MC in the Somme department in Northern France, to evaluate clinical characteristics, and to search for risk factors for both collagenous colitis (CC) and lymphocytic colitis (LC).
Design
Between January 1, 2005, and December 31, 2007, four pathology units in the Somme department recorded all new cases of MC diagnosed in patients living in the area. Colonic biopsies were reviewed by 4 pathologists together. For each incident case, demographic, clinical, endoscopic, and biological data were collected according to methodology of the EPIMAD registry.
Results
One hundred and thirty cases of MC, including 87 CC and 43 LC, were recorded during the three-year study. The mean annual incidence for MC was 7.9/105 inhabitants, 5.3/105 inhabitants for CC, and 2.6/105 inhabitants for LC. Annual standardized incidence of Crohn’s disease and ulcerative colitis in the EPIMAD registry during the same period (2005–2007) were 7.4/105 and 4.9/105, respectively. Median age at diagnosis was 63 years for MC, 70 for CC, and 48 for LC. The female-to-male gender ratio was 3.5 for MC, 4.1 for CC, and 2.6 for LC. Median time to diagnosis was 8 weeks. Chronic diarrhea and abdominal pain were, respectively, present in 93 and 47 % of the cases. An autoimmune disease was associated in 28 % of MC cases. At diagnosis, proton pump inhibitor treatment was more often reported in CC than in LC (46 vs 16 %; p = 0.003). Budesonide was effective on diarrhea in 77 % of patients, and thirteen percent of patients became steroid dependent.
Conclusion
This population-based study shows that the incidence of MC in France is high and similar to Crohn’s disease incidence and confirms that this condition is associated with female gender, autoimmune diseases, and medications.
Similar content being viewed by others
Abbreviations
- MC:
-
Microscopic colitis
- CC:
-
Collagenous colitis
- LC:
-
Lymphocytic colitis
- NSAIDs:
-
Nonsteroidal anti-inflammatory drugs
- PPIs:
-
Proton pump inhibitors
References
Bohr J, Tysk C, Eriksson S, Järnerot G. Collagenous colitis in Orebro, Sweden, an epidemiological study 1984–1993. Gut. 1995;37:394–397.
Bjørnbak C, Engel PJ, Nielsen PL, Munck LK. Microscopic colitis: clinical findings, topography and persistence of histopathological subgroups. Aliment Pharmacol Ther. 2011;34:1225–1234.
Thörn M, Sjöberg D, Ekbom A, et al. Microscopic colitis in Uppsala health region, a population-based prospective study 2005–2009. Scand J Gastroenterol. 2013;48:825–830.
Gentile NM, Khanna S, Loftus EV Jr, et al. The epidemiology of microscopic colitis in Olmsted County from 2002 to 2010: a population-based study. Clin Gastroenterol Hepatol. 2014;12:838–842.
Stewart M, Andrews CN, Urbanski S, et al. The association of coeliac disease and microscopic colitis: a large population-based study. Aliment Pharmacol Ther. 2011;33:1340–1349.
Agnarsdottir M, Gunnlaugsson O, Orvar KB, et al. Collagenous and lymphocytic colitis in Iceland. Dig Dis Sci. 2002;47:1122–1128.
Olesen M, Eriksson S, Bohr J, et al. Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993–1998. Gut. 2004;53:346–350.
Williams JJ, Kaplan GG, Makhija S, et al. Microscopic colitis-defining incidence rates and risk factors: a population-based study. Clin Gastroenterol Hepatol. 2008;6:35–40.
Fernández-Bañares F, Salas A, Forné M, et al. Incidence of collagenous and lymphocytic colitis: a 5-year population-based study. Am J Gastroenterol. 1999;94:418–423.
Fernández-Bañares F, Salas A, Esteve M, et al. Evolution of the incidence of collagenous colitis and lymphocytic colitis in Terrassa, Spain: a population-based study. Inflamm Bowel Dis. 2011;17:1015–1020.
Tong J, Zheng Q, Zhang C, et al. Incidence, prevalence, and temporal trends of microscopic colitis: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110:265–276.
Bonderup OK, Fenger-Grøn M, Wigh T, et al. Drug exposure and risk of microscopic colitis: a nationwide Danish case-control study with 5751 cases. Inflamm Bowel Dis. 2014;20:1702–1707.
Park T, Cave D, Marshall C. Microscopic colitis: A review of etiology, treatment and refractory disease. World J Gastroenterol. 2015;21:8804–8810.
Pardi DS, Loftus EV Jr, Smyrk TC, et al. The epidemiology of microscopic colitis: a population based study in Olmsted County. Minnesota. Gut. 2007;56:504–508.
Beaugerie L, Pardi DS. Review article: drug-induced microscopic colitis—proposal for a scoring system and review of the literature. Aliment Pharmacol Ther. 2005;22:277–284.
Gower-Rousseau C, Salomez JL, Dupas JL, et al. Incidence of inflammatory bowel disease in northern France (1988-1990). Gut. 1994;35:1433–1438.
Limsui D, Pardi DS, Smyrk TC, et al. Observer variability in the histologic diagnosis of microscopic colitis. Inflamm Bowel Dis. 2009;15:35–38.
Libbrecht L, Croes R, Ectors N, et al. Microscopic colitis with giant cells. Histopathology. 2002;40:335–338.
Fernández-Bañares F, Casalots J, Salas A, et al. Paucicellular lymphocytic colitis: is it a minor form of lymphocytic colitis? A clinical pathological and immunological study. Am J Gastroenterol. 2009;104:1189–1198.
Rubio CA, Lindholm J. Cryptal lymphocytic coloproctitis: a new phenotype of lymphocytic colitis? J Clin Pathol. 2002;55:138–140.
Yuan S, Reyes V, Bronner MP. Pseudomembranous collagenous colitis. Am J Surg Pathol. 2003;27:1375–1379.
Sandmeier D, Bouzourene H. A rare variant of microscopic colitis with granulomatous inflammation. Histopathology. 2005;47:644–645.
Macaigne G, Lahmek P, Locher C, et al. Microscopic colitis or functional bowel disease with diarrhea: a French prospective multicenter study. Am J Gastroenterol. 2014;109:1461–1470.
Lazenby AJ, Yardley JH, Giardiello FM, et al. Lymphocytic (“microscopic”) colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol. 1989;20:18–28.
Barta Z, Mekkel G, Csípo I, et al. Microscopic colitis: a retrospective study of clinical presentation in 53 patients. World J Gastroenterol. 2005;11:1351–1355.
Jobse P, Flens MJ, Loffeld RJ. Collagenous colitis: description of a single centre series of 83 patients. Eur J Intern Med. 2009;20:499–502.
Katsinelos P, Katsos I, Patsiaoura K, et al. A new endoscopic appearance of collagenous colitis. Endoscopy. 1997;29:135.
Richieri JP, Bonneau HP, Cano N, et al. Collagenous colitis: an unusual endoscopic appearance. Gastrointest Endosc. 1993;39:192–194.
Pardi DS, Ramnath VR, Loftus EV Jr, et al. Lymphocytic colitis: clinical features, treatment, and outcomes. Am J Gastroenterol. 2002;97:2829–2833.
Pokorny CS, Kneale KL, Henderson CJ. Progression of collagenous colitis to ulcerative colitis. J Clin Gastroenterol. 200;32:435-8.
Münch A, Bohr J, Miehlke S, et al. Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial. Gut. 2016;65:47–56.
Chande N, MacDonald JK, McDonald JW. Interventions for treating microscopic colitis: a Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials. Am J Gastroenterol. 2009;104:235–241.
Miehlke S, Madisch A, Karimi D, et al. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study. Gastroenterology. 2009;136:2092–2100.
Vigren L, Olesen M, Benoni C, Sjöberg K. An epidemiological study of collagenous colitis in southern Sweden from 2001-2010. World J Gastroenterol. 2012;18:2821–2826.
Wickbom A, Bohr J, Eriksson S, Udumyan R, Nyhlin N, Tysk C. Stable incidence of collagenous colitis and lymphocytic colitis in Örebro, Sweden, 1999-2008: a continuous epidemiologic study. Inflamm Bowel Dis. 2013;19:2387–2393.
Loftus CG, Loftus EV Jr, Harmsen WS, et al. Update on the incidence and prevalence of Crohn’s disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000. Inflamm Bowel Dis. 2007;13:254–261.
Pinchbeck BR, Kirdeikis J, Thomson AB. Inflammatory bowel disease in northern Alberta. An epidemiologic study. J Clin Gastroenterol. 1988;10:505–515.
Tysk C, Jarnerot G. Ulcerative proctocolitis in Orebro, Sweden. A retrospective epidemiologic study, 1963–1987. Scand J Gastroenterol. 1992;27:945–950.
Lindberg E, Jornerot G. The incidence of Crohn’s disease is not decreasing in Sweden. Scand J Gastroenterol. 1991;26:495–500.
Brahme F, Lindstrom C, Wenckert A. Crohn’s disease in a defined population. An epidemiological study of incidence, prevalence, mortality, and secular trends in the city of Malmo, Sweden. Gastroenterology. 1975;69:342–351.
Stewenius J, Adnerhill I, Ekelund G, et al. Ulcerative colitis and indeterminate colitis in the city of Malmo, Sweden. A 25-year incidence study. Scand J Gastroenterol. 1995;30:38–43.
Ekbom A, Helmick C, Zack M, et al. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology. 1991;100:350–358.
Bjornsson S, Johannsson JH. Inflammatory bowel disease in Iceland, 1990–1994: a prospective, nationwide, epidemiological study. Eur J Gastroenterol Hepatol. 2000;12:31–38.
Somme Microscopic colitis study group:
Gastroenterologists E. Bartoli, A. Bental, F. Brazier, J. Butel, D. Capron-Chivrac, H. Coevoet, G. Cohen, I. Dadamessi, R. Delcenserie, T. Delgrange, P. Descombes, JL. Dupas, B. Heyman, JP. Joly, M. Lagarde, D. Laude, H. Mancheron, E. Nguyen-Khac, A. Papazian, B. Pauwels, M. Pauwels, JC. Prevost, N. Reix-Branche, A. Rudelli, F. Sevenet, C. Triplet, M. Wantiez.
Pathologists
D. Chatelain, C. Cordonnier-Bryselbout, C. Ghighi, F. Lamarche, C. Lelarge, F. Nagorniewicz, J. Petit, T. Petit, P. Richard, H. Sevestre, F. Thelu
Author contributions
M. Fumery: Concept and study design, interpretation of data, drafting of the manuscript, M. Kohut: Concept and study design, data collection, interpretation of data, critical revision of the manuscript, C. Gower-Rousseau: Concept and study design, critical revision of the manuscript, A. Duhamel: Statistical analysis, critical revision of the manuscript, F. Brazier: Critical revision of the manuscript, F. Thelu: Pathology, slide reading, F. Nagorniewicz: Pathology, slide reading, F. Lamarche: Pathology, slide reading, E. Nguyen-Khac: Concept and study design, critical revision of the manuscript, C. Sabbagh: Interpretation of data, critical revision of the manuscript, J. Loreau: Data collection, interpretation of data, J. F. Colombel: Concept and study design, critical revision of the manuscript, G. Savoye: Concept and study design, critical revision of the manuscript, D. Chatelain: Concept and study design, pathology, slide reading, critical revision of the manuscript, J. L. Dupas: Concept and study design, interpretation of data, drafting of the manuscript and critical revision of the manuscript.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest
There is no conflict of interest for this manuscript.
Additional information
Mathurin Fumery and Mathieu Kohut have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Fumery, M., Kohut, M., Gower-Rousseau, C. et al. Incidence, Clinical Presentation, and Associated Factors of Microscopic Colitis in Northern France: A Population-Based Study. Dig Dis Sci 62, 1571–1579 (2017). https://doi.org/10.1007/s10620-016-4306-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-016-4306-z